Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 24 studies | 22% ± 8% | |
memory B cell | 14 studies | 25% ± 6% | |
conventional dendritic cell | 3 studies | 37% ± 24% | |
dendritic cell | 3 studies | 29% ± 2% |
Insufficient scRNA-seq data for expression of CLECL1P at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 42.03 | 564 / 578 | 54% | 1.40 | 626 / 1155 |
breast | 81% | 16.77 | 374 / 459 | 54% | 1.48 | 605 / 1118 |
thymus | 74% | 22.20 | 483 / 653 | 40% | 1.09 | 245 / 605 |
stomach | 85% | 17.81 | 304 / 359 | 28% | 0.93 | 80 / 286 |
kidney | 60% | 14.54 | 53 / 89 | 49% | 1.25 | 442 / 901 |
intestine | 84% | 92.66 | 814 / 966 | 18% | 1.04 | 95 / 527 |
uterus | 69% | 9.31 | 117 / 170 | 32% | 0.67 | 147 / 459 |
bladder | 81% | 19.48 | 17 / 21 | 20% | 0.71 | 100 / 504 |
lymph node | 0% | 0 | 0 / 0 | 100% | 58.96 | 29 / 29 |
spleen | 100% | 386.20 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 83% | 17.53 | 204 / 245 | 13% | 0.25 | 64 / 502 |
peripheral blood | 91% | 573.24 | 844 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 84% | 17.88 | 216 / 258 | 5% | 0.09 | 12 / 230 |
esophagus | 68% | 11.19 | 983 / 1445 | 21% | 0.43 | 38 / 183 |
skin | 48% | 5.71 | 866 / 1809 | 40% | 1.23 | 188 / 472 |
adipose | 87% | 23.07 | 1047 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 38% | 3.87 | 123 / 328 | 45% | 1.25 | 80 / 178 |
brain | 43% | 7.72 | 1131 / 2642 | 38% | 1.14 | 267 / 705 |
ovary | 46% | 5.28 | 82 / 180 | 34% | 0.59 | 145 / 430 |
liver | 63% | 8.12 | 143 / 226 | 15% | 0.39 | 60 / 406 |
tonsil | 0% | 0 | 0 / 0 | 64% | 1.75 | 29 / 45 |
blood vessel | 64% | 13.17 | 851 / 1335 | 0% | 0 | 0 / 0 |
heart | 39% | 4.85 | 333 / 861 | 0% | 0 | 0 / 0 |
muscle | 11% | 0.85 | 92 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.11 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0097323 | Biological process | B cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | CLECL1P |
Protein name | Putative C-type lectin-like domain family 1 (C-type lectin-like domain family 1 pseudogene) (Dendritic cell-associated lectin 1) (DC-associated lectin-1) (DCAL-1) |
Synonyms | DCAL1 CLECL1 |
Description | FUNCTION: May function in mediating immune cell-cell interactions. May act as a T-cell costimulatory molecule, enhancing anti-CD3-induced proliferation. May play a role in the interaction of dendritic cells with T-cells and the cells of the adaptive immune response. . |
Accessions | Q8IZS7 |